NTRB 株価推移チャート
NTRB 財務
Nutriband Inc
$3.75
-1.05%
$-0.04
終値： May 08, 16:00:00 GMT-4
$3.66
-2.39%
$-0.08
アフターマーケット：May 08, 20:00:00 GMT-4
戻る
Nutriband Inc (NTRB) 財務
主要データ
前終値
$3.79
始値
$3.83
当日レンジ
$3.66 - $3.83
52週レンジ
$3.42 - $11.67
取引高
17.5K
平均取引高
25.0K
配当利回り
--
1株当たり利益(TTM)
-1.12
時価総額
$44.5M
NTRBとは何ですか？
Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. The company is headquartered in Orlando, Florida. The company went IPO on 2017-06-20. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. The company is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
